Xeris Biopharma Ownership | Who Owns Xeris Biopharma?
Xeris Biopharma Ownership Summary
Xeris Biopharma is owned by 43.17% institutional investors, 3.91% insiders, and 52.92% retail investors. Blackrock is the largest institutional shareholder, holding 7.35% of XERS shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.85% of its assets in Xeris Biopharma shares.
XERS Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Xeris Biopharma | 43.17% | 3.91% | 52.92% |
Sector | Healthcare Stocks | 47.25% | 8.01% | 44.75% |
Industry | Biotech Stocks | 45.35% | 7.81% | 46.83% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Vanguard Total Stock Mkt Idx Inv | 4.25M | 2.85% | - |
iShares Russell 2000 ETF | 3.59M | 2.41% | -8.08K |
Vanguard Institutional Extnd Mkt Idx Tr | 2.29M | 1.53% | 39.10K |
Fidelity Small Cap Index | 1.43M | 0.96% | -30.83K |
iShares Russell 2000 Growth ETF | 1.24M | 0.83% | - |
CREF Stock R1 | 917.64K | 0.62% | - |
State St Russell Sm/Mid Cp® Indx NL Cl C | 871.04K | 0.58% | -30.70K |
Fidelity Extended Market Index | 867.55K | 0.58% | -58.48K |
Vanguard Russell 2000 ETF | 640.69K | 0.43% | -3.98K |
Kennedy Micro Cap | 526.07K | 0.35% | 526.07K |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Aug 12, 2024 | Schmid John P. | - | Buy | $10.15K |
Aug 09, 2024 | Schmid John P. | - | Buy | $10.13K |
May 10, 2024 | Schmid John P. | - | Buy | $10.31K |
Mar 14, 2024 | Schmid John P. | - | Buy | $9.72K |
Nov 27, 2023 | SHERMAN JEFFREY W | - | Buy | $10.10K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2024 Q3 | 2 | - |
2024 Q2 | 1 | - |
2024 Q1 | 1 | - |
2023 Q4 | 6 | - |
2023 Q3 | 1 | - |
XERS Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools